- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A pharmacist complained about repeated calls from Astellas reps about formulary approval. The Panel found the pharmacist’s wishes weren’t observed (breach Clauses…
A Seretide Evohaler digital banner in Pulse rotated across 4 frames, but a media agency set frame 2 as a static ‘back-up’.…
A member of the public alleged POM promotional panels at ExCeL London were visible/readable from a public coffee area. Panel found the…
Lilly challenged Roche’s use of “first-line maintenance” for Tarceva across a leavepiece, ad and sponsored feature. Panel found breaches, but the Appeal…
A sponsored HSJ ‘special report’ on atrial fibrillation looked like independent editorial and favoured dronedarone. PMCPA ruled Sanofi-Aventis was inextricably linked to…
A consultant challenged an Asacol leavepiece claiming “up to 72% treatment success”. The Panel found breaches, but on appeal the Appeal Board…
Alcon’s Travatan BAK-free ad used a thornless rose and animal/in vitro data implying better tolerability vs BAK formulation. PMCPA found the ad…
BMJ analysis suggested 3 Ipsen trials were missing EUCTR results. Panel found 2 trials had no UK nexus and 1 was cancelled…
Abbott disclosed that one representative had not taken/passed the ABPI Medical Representatives Examination after exemptions ended in 2006. PMCPA ruled a breach…
Two public complaints said an Onglyza advertorial in Health Service Journal was inappropriate/too technical and potentially public-facing. Panel found a Clause 11.1…
PMCPA case AUTH/3117/11/18 (Director v Seqirus) concerned clinical trial disclosure but was ruled outwith the scope of the ABPI Code (2016). No…
BMJ analysis suggested Teva had unreported EUCTR trial results (72% disclosed). Panel initially found Clause 9.1 breaches for two UK-nexus trials, but…
Merz’s Bocouture ad in Cosmetic News implied 1:1 clinical conversion/equal potency vs Botox. PMCPA ruled it breached a prior undertaking and failed…
A pharmacist alleged an ALK-Abelló rep wrongly said EpiPen was discontinued, Jext administration was identical, and Jext had 24-month shelf life. Panel…
Vifor voluntarily admitted three Ferinject ads placed by global colleagues in international journals were not certified under the UK ABPI Code. PMCPA…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.